Skip to main content
. 2021 May 24;2(4):311–323. doi: 10.1016/j.hroo.2021.05.006

Table 1.

Patient characteristics

All patients (n = 76) Paroxysmal AF (n = 28) Persistent AF (n = 48) P value
Age (years) 71.9 ± 8.2 69.9 ± 10.2 73.2 ± 6.7 .09
Sex
 Male 40 (53) 12 (43) 28 (58) .19
 Female 36 (47) 16 (57) 20 (42) .19
BMI (kg/m2) 23.2 ± 3.6 22.6 ± 2.7 23.6 ± 4.0 .24
History of present and past illness
 Hypertension 39 (51) 14 (50) 25 (52) .86
 Diabetes mellitus 18 (24) 4 (14) 14 (29) .14
 Dyslipidemia 30 (39) 12 (43) 18 (38) .64
 Coronary artery disease 17 (22) 7 (25) 10 (21) .67
 Cerebral infarction 14 (18) 6 (21) 8 (17) .61
 Sleep apnea 1 (1) 0 (0) 1 (1) .44
Smoking 28 (37) 11 (39) 17 (35) .74
Alcohol use 22 (29) 4 (14) 18 (38) <.05
CHADS2 score 2.6 ± 1.1 2.5 ± 1.1 2.6 ± 1.1 .50
CHA2DS2-VASc score 4.0 ± 1.4 4.0 ± 1.3 4.1 ± 1.5 .85
Surgical procedure
 Valve replacement/repair 51 (67) 21 (75) 30 (63) .26
 Aorta replacement 6 (8) 0 (0) 6 (13) .05
 CABG 1 (1) 0 (0) 1 (2) .44
 Combined (CABG and valve) 14 (18) 7 (25) 7 (15) .26
 Combined (aorta and valve) 3 (4) 0 (0) 3 (6) .17
 Combined (ASD closure and valve) 1 (1) 0 (0) 1 (2) .44
BUN (mg/dL) 25 ± 13 23 ± 14 25 ± 12 .39
Cr (mg/dL) 1.4 ± 1.8 1.8 ± 2.8 1.2 ± 0.6 .13
BNP (pg/mL) 358 ± 435 430 ± 500 311 ± 388 .31
eGFR (mL/min/1.73 m2) 51 ± 20 53 ± 22 50 ± 19 .45
LAD (mm) 52 ± 10 47 ± 8 54 ± 11 <.01
LVDd (mm) 53 ± 9 52 ± 9 53 ± 9 .45
EF (%) 59 ± 12 62 ± 13 58 ± 13 .13
E/e' 22 ± 13 25 ± 13 20 ± 12 .11
AR II°-III° 19 (25) 5 (18) 14 (29) .27
AS moderate-severe 18 (24) 8 (29) 10 (21) .44
MR II°-III° 47 (62) 17 (61) 30 (63) .88
MS moderate-severe 11 (14) 6 (21) 5 (10) .19
EAT volume (mL) 89 ± 46 71 ± 28 99 ± 51 <.05
EAT volume corrected by BMI 3.8 ± 1.6 3.1 ± 1.1 4.1 ± 1.8 <.01

Data are given as mean ± SD or n (%).

AF = atrial fibrillation; AR = aortic regurgitation; AS = aortic stenosis; ASD = atrial septal defect; BMI = body mass index; BNP = brain natriuretic peptide; BUN = blood urea nitrogen; CABG = coronary artery bypass graft; Cr = creatinine; E/e = the ratio of the peak early mitral inflow velocity (E) over the early diastolic mitral annular velocity (e′); EAT = epicardial adipose tissue; EF = ejection fraction; eGFR = estimated glomerular filtration rate; LAD = left atrial diameter; LVDd = left ventricular end-diastolic diameter; MR = mitral regurgitation; MS = mitral stenosis.